CONMED Balance Sheet Health
Financial Health criteria checks 3/6
CONMED has a total shareholder equity of $932.9M and total debt of $938.8M, which brings its debt-to-equity ratio to 100.6%. Its total assets and total liabilities are $2.3B and $1.4B respectively. CONMED's EBIT is $147.6M making its interest coverage ratio 3.9. It has cash and short-term investments of $38.5M.
Key information
100.6%
Debt to equity ratio
US$938.79m
Debt
| Interest coverage ratio | 3.9x |
| Cash | US$38.47m |
| Equity | US$932.90m |
| Total liabilities | US$1.38b |
| Total assets | US$2.32b |
Recent financial health updates
Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?
Nov 25
Is CONMED (NYSE:CNMD) Using Too Much Debt?
Mar 28CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt
Nov 30Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?
Aug 24These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively
May 17Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden
Feb 14Recent updates
CONMED (NYSE:CNMD) Has Affirmed Its Dividend Of $0.20
Dec 13Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?
Nov 25CONMED's (NYSE:CNMD) Earnings Are Weaker Than They Seem
Nov 07Earnings Beat: CONMED Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Nov 02Should You Investigate CONMED Corporation (NYSE:CNMD) At US$71.92?
Oct 01Why We're Not Concerned About CONMED Corporation's (NYSE:CNMD) Share Price
Sep 12CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20
Aug 15CONMED Corporation's (NYSE:CNMD) Intrinsic Value Is Potentially 97% Above Its Share Price
Jul 17AirSeal Concerns Have Let Too Much Air Out Of Conmed's Valuation
Jun 21There Is A Reason CONMED Corporation's (NYSE:CNMD) Price Is Undemanding
Jun 01Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching
Apr 18Is CONMED (NYSE:CNMD) Using Too Much Debt?
Mar 28CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%
Feb 15US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results
Feb 03Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?
Jan 08Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects
Dec 18CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt
Nov 30Conmed: Sector Derating And A New Competitive Threat Shouldn't Overshadow A Solid Core Business
Oct 28Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?
Sep 22Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?
Aug 24Conmed: Reiterate Buy Rating As Earnings Are Expected To Grow Strongly
Jul 28Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?
Jun 08These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively
May 17Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)
Apr 28Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching
Mar 10Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden
Feb 14CONMED Non-GAAP EPS of $0.42 misses by $0.48, revenue of $250.9M misses by $51.58M
Feb 02Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)
Jan 24ConMed: Still Fairly Priced, Turning More Constructive
Dec 09At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?
Nov 18Conmed withdraws FY22 guidance on software implementation-related disruption
Nov 15Financial Position Analysis
Short Term Liabilities: CNMD's short term assets ($641.0M) exceed its short term liabilities ($282.3M).
Long Term Liabilities: CNMD's short term assets ($641.0M) do not cover its long term liabilities ($1.1B).
Debt to Equity History and Analysis
Debt Level: CNMD's net debt to equity ratio (96.5%) is considered high.
Reducing Debt: CNMD's debt to equity ratio has reduced from 113.2% to 100.6% over the past 5 years.
Debt Coverage: CNMD's debt is not well covered by operating cash flow (19.2%).
Interest Coverage: CNMD's interest payments on its debt are well covered by EBIT (3.9x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 06:53 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
CONMED Corporation is covered by 14 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Travis Steed | Barclays |
| Travis Steed | BofA Global Research |
| Kristen Stewart | CL King & Associates, Inc. |